Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CORBFNASDAQ:DCGONASDAQ:PIIINASDAQ:TOI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCORBFGlobal Cord Blood$1.05$0.92$0.25▼$2.00$127.63M-0.64174,991 shsN/ADCGODocGo$2.28+1.8%$2.77$2.02▼$5.68$232.52M1.12747,258 shs499,581 shsPIIIP3 Health Partners$8.75-1.2%$8.99$7.00▼$40.50$62.84M0.9620,333 shs9,560 shsTOIOncology Institute$2.50-14.1%$1.39$0.13▼$3.50$188.90M0.22813,707 shs2.99 million shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCORBFGlobal Cord Blood0.00%+10.53%+31.25%+3.96%-16.00%DCGODocGo0.00%+8.21%-15.15%-53.14%-37.95%PIIIP3 Health Partners-0.89%+2.19%+2.72%-7.71%-60.29%TOIOncology Institute-12.08%+21.76%+155.26%+268.31%+153.04%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCORBFGlobal Cord BloodN/AN/AN/AN/AN/AN/AN/AN/ADCGODocGo2.3588 of 5 stars3.41.00.00.02.40.81.9PIIIP3 Health Partners2.4396 of 5 stars3.34.00.00.02.70.80.6TOIOncology Institute0.6963 of 5 stars0.03.00.00.02.71.70.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCORBFGlobal Cord Blood 0.00N/AN/AN/ADCGODocGo 2.83Moderate Buy$4.89114.55% UpsidePIIIP3 Health Partners 2.50Moderate Buy$16.2585.71% UpsideTOIOncology Institute 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest PIII, DCGO, TOI, and CORBF Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/21/2025PIIIP3 Health PartnersLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$50.00 ➝ $20.004/8/2025DCGODocGoNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$4.00 ➝ $4.002/28/2025DCGODocGoStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$6.50 ➝ $5.502/28/2025DCGODocGoDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$5.00 ➝ $2.852/28/2025DCGODocGoNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$7.00 ➝ $4.00(Data available from 4/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCORBFGlobal Cord Blood$196.12M0.65$0.75 per share1.40N/A∞DCGODocGo$616.56M0.38$0.10 per share23.62$2.93 per share0.78PIIIP3 Health Partners$1.50B0.04$3.77 per share2.32$0.45 per share19.44TOIOncology Institute$393.41M0.48N/AN/A$0.77 per share3.25Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCORBFGlobal Cord Blood$79.04MN/A0.00∞N/AN/AN/AN/AN/ADCGODocGo$6.86M$0.178.1428.5014.164.35%8.90%5.72%5/8/2025 (Estimated)PIIIP3 Health Partners-$57.77M-$49.00N/AN/AN/A-6.95%-71.31%-11.93%5/6/2025 (Estimated)TOIOncology Institute-$83.07M-$0.71N/A∞N/A-17.63%-186.83%-34.58%5/14/2025 (Estimated)Latest PIII, DCGO, TOI, and CORBF EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025PIIIP3 Health Partners-$5.00N/AN/AN/A$362.09 millionN/A5/8/2025Q1 2025DCGODocGo-$0.01N/AN/AN/A$104.25 millionN/A3/27/2025Q4 2024PIIIP3 Health Partners-$8.50-$16.00-$7.50-$0.36$378.88 million$370.69 million3/24/2025Q4 2024TOIOncology Institute-$0.08-$0.14-$0.06-$0.14$109.15 million$100.27 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCORBFGlobal Cord BloodN/AN/AN/AN/AN/ADCGODocGoN/AN/AN/AN/AN/APIIIP3 Health PartnersN/AN/AN/AN/AN/ATOIOncology InstituteN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCORBFGlobal Cord BloodN/AN/AN/ADCGODocGoN/A2.192.19PIIIP3 Health Partners1.110.530.53TOIOncology Institute5.912.492.27Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCORBFGlobal Cord BloodN/ADCGODocGo56.44%PIIIP3 Health Partners7.75%TOIOncology Institute36.86%Insider OwnershipCompanyInsider OwnershipCORBFGlobal Cord Blood0.50%DCGODocGo2.70%PIIIP3 Health Partners15.76%TOIOncology Institute8.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCORBFGlobal Cord Blood1,200121.55 millionN/ANot OptionableDCGODocGo2,920101.98 million99.30 millionOptionablePIIIP3 Health Partners5007.18 million294.74 millionNot OptionableTOIOncology Institute66075.56 million68.38 millionNot OptionablePIII, DCGO, TOI, and CORBF HeadlinesRecent News About These CompaniesOncology Institute (NASDAQ:TOI) Stock Price Up 6.3% - Still a Buy?April 26 at 2:55 AM | marketbeat.comThe Oncology Institute Announces First Quarter 2025 Earnings Release Date and Conference CallApril 23, 2025 | globenewswire.comTopicus.com Inc. Announces Release Date for First Quarter ResultsApril 14, 2025 | globenewswire.comWhy The Oncology Institute, Inc.’s (TOI) Stock Is Up 9.33%April 10, 2025 | aaii.comWhy The Oncology Institute, Inc.’s (TOI) Stock Is Up 17.46%April 3, 2025 | aaii.comWhy The Oncology Institute, Inc.’s (TOI) Stock Is Up 10.53%April 2, 2025 | aaii.comThe Oncology Institute, Inc. (TOI): Among Stocks Insiders Were Buying In Q1 2025April 1, 2025 | msn.comThe Oncology Institute announces launch of the Florida Oncology NetworkMarch 31, 2025 | markets.businessinsider.comTOI Launches Florida Oncology Network, a Fully Delegated Cancer Care Network, and Announces Four Additional Value-based Contracts in Q1March 31, 2025 | globenewswire.comDaniel Virnich Buys 22,640 Shares of The Oncology Institute, Inc. (NASDAQ:TOI) StockMarch 29, 2025 | marketbeat.comInsider Buying: The Oncology Institute, Inc. (NASDAQ:TOI) Director Buys 90,562 Shares of StockMarch 29, 2025 | marketbeat.comInsider Buying: The Oncology Institute, Inc. (NASDAQ:TOI) CEO Acquires 22,640 Shares of StockMarch 29, 2025 | insidertrades.comQ4 2024 Oncology Institute Inc Earnings CallMarch 26, 2025 | finance.yahoo.comOncology Institute Full Year 2024 Earnings: US$0.86 loss per share (vs US$0.92 loss in FY 2023)March 26, 2025 | uk.finance.yahoo.comThe oncology institute targets profitability and $460M-$480M revenue in 2025March 25, 2025 | msn.comThe Oncology Institute, Inc. (TOI) Q4 2024 Earnings Call TranscriptMarch 25, 2025 | seekingalpha.comThe Oncology Institute announces $16.5M private placementMarch 24, 2025 | markets.businessinsider.comThe Oncology Institute sees FY25 revenue $460M-$480MMarch 24, 2025 | markets.businessinsider.comThe Oncology Institute reports Q4 EPS (14c) vs. (21c) last yearMarch 24, 2025 | markets.businessinsider.comThe Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025March 24, 2025 | globenewswire.comThe Oncology Institute Announces $16.5 million Private PlacementMarch 24, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePIII, DCGO, TOI, and CORBF Company DescriptionsGlobal Cord Blood NYSE:CORBF$1.05 0.00 (0.00%) As of 04/28/2025Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.DocGo NASDAQ:DCGO$2.28 +0.04 (+1.79%) Closing price 04:00 PM EasternExtended Trading$2.26 -0.02 (-0.88%) As of 06:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.P3 Health Partners NASDAQ:PIII$8.75 -0.11 (-1.24%) Closing price 04:00 PM EasternExtended Trading$8.63 -0.12 (-1.37%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.Oncology Institute NASDAQ:TOI$2.50 -0.41 (-14.09%) Closing price 04:00 PM EasternExtended Trading$2.43 -0.07 (-2.80%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Coca-Cola Company Stock Can Bubble to New Highs This Year Intel: Good Quarter, Bad Vibes, Guidance Rattles Investors Don’t Be Fooled by the Bounce: The Market Storm Isn’t Over Yet Domino’s Pizza Builds Leverage: Analysts Raise Price Targets 5 Mid-Cap Stocks Insiders Are Buying This Year Alphabet Rebounds After Strong Earnings and Buyback Announcement Occidental’s Hidden Gem: How OxyChem Could Boost Profits T-Mobile US: The Un-Carrier Is an Indisputable Buy on the Dip Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
